Lloyd, K.M. 2nd, Dennis, M., Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 58 (1963), 136–142.
Pilarski, R., Cowden syndrome: a critical review of the clinical literature. J Genet Couns 18 (2009), 13–27.
Pal, A., Barber, T.M., Van de Bunt, M., Rudge, S.A., Zhang, Q., Lachlan, K.L., et al. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med 367 (2012), 1002–1011.
Sardinoux, M., Raingeard, I., Bessis, D., Coupie, I., Renard, E., Bringer, J., Cowden syndrome, or multiple hamartomatous tumours syndrome in clinical endocrinology. Ann Endocrinol 71 (2010), 264–273.
Pilarski, R., Burt, R., Kohlman, W., Pho, L., Shannon, K.M., Swisher, E., Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 105 (2013), 1607–1616.
Boosani, C.S., Agrawal, D.K., PTEN modulators: a patent review. Expert Opin Ther Pat 23 (2013), 569–580.
Lok, C., Viseux, V., Avril, M.F., Richard, M.A., Gondry-Jouet, C., Deramond, H., et al. Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore) 84 (2005), 129–136.
Ahern, C.H., Shih, Y.C., Dong, W., Parmigiani, G., Shen, Y., Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer 111 (2014), 1542–1545.
Tutluer, S., Tanriover, M.D., Guven, G.S., Cowden syndrome: a major indication for extensive cancer surveillance. Med Oncol 29 (2012), 1365–1368.
